Loading clinical trials...
Loading clinical trials...
Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascu...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
NCT07052799 · Myocardial Infarction (MI), Cardiovascular Events, and more
NCT07444957 · Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), and more
NCT07436429 · Myocardial Infarction (MI), ST-Elevation Myocardial Infarction, and more
NCT07354646 · Myocardial Infarction (MI), Hypertrophic Cardiomyopathy (HCM), and more
NCT07351825 · Ischemic Heart Disease (IHD), Myocardial Infarction (MI)
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions